Objective Whether fecal microbiota transplantation (FMT) in patients with irritable bowel
syndrome (IBS) is effective in improving outcomes remains controversial. We assessed the …

Background Gut microbiome dysbiosis has been implicated in various gastrointestinal and
extra-gastrointestinal diseases, but evidence on the efficacy and safety of fecal microbiota …

Clostridioides difficile infections (CDIs) have decreased in the past years, but since 2021,
some hospitals have reported an increase in CDI rates. CDI remains a global concern and …

Introduction Clostridiodes difficile infection (CDI) is a life-threatening illness that has been
labelled as an urgent threat by the Centers for Disease prevention (CDC). Areas Covered …

In recent years, there has been growing concern about the impact of the gastrointestinal
microbiome on human health outcomes. To clarify the evidence for a link between the …

Given the importance of gut microbial homeostasis in maintaining health, there has been
considerable interest in developing innovative therapeutic strategies for restoring gut …

Background Clostridioides difficile (formerly known as Clostridium difficile) is a bacterium
that can cause potentially life‐threatening diarrheal illness in individuals with an unhealthy …

Clostridioides difficile colonizes a polymicrobial environment in the intestine and is a
causative agent for antibiotic-associated diarrhea (AAD) and pseudomembranous colitis …

Clostridioides difficile (C. difficile) is progressively colonizing humans and animals living
with humans. During this process, hypervirulent strains and mutated toxin A and B of C …

Background There is growing interest in faecal microbiota transplantation (FMT) as a
treatment for recurrent Clostridioides difficile infection (CDI), but evidence on the diverse …